Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.00 |
| Mar 31, 2026 | -301.00 |
| Dec 31, 2025 | 398.00 |
| Sep 30, 2025 | -14,717.00 |
| Jun 30, 2025 | -103.00 |
| Mar 31, 2025 | -192.00 |
| Dec 31, 2024 | -505.00 |
| Sep 30, 2024 | -131.00 |
| Jun 30, 2024 | -988.00 |
| Mar 31, 2024 | 87.00 |
| Dec 31, 2023 | -614.00 |
| Sep 30, 2023 | -16,659.00 |
| Jun 30, 2023 | -423.00 |
| Mar 31, 2023 | -488.00 |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | 603.00 |
| Mar 31, 2022 | -331.00 |
| Dec 31, 2021 | -3,122.00 |
| Sep 30, 2021 | -693.00 |
| Jun 30, 2021 | 140.00 |